Monday, December 12, 2016

UPDATE 2-Bayer, Versant invest $225 million in biotech venture

* Focus on cardiovascular, neurodegenerative conditions

(Adds comments from Bayer/Versant executives)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)